Halozyme Therapeutics Inc. (HALO)’s Day in Review: Closing at 59.39, Up by 0.22

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $59.26 in the prior trading day, Halozyme Therapeutics Inc. (NASDAQ: HALO) closed at $59.39, up 0.22%. In other words, the price has increased by $0.22 from its previous closing price. On the day, 0.72 million shares were traded. HALO stock price reached its highest trading level at $60.14 during the session, while it also had its lowest trading level at $58.64.

Ratios:

Our goal is to gain a better understanding of HALO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.43. For the most recent quarter (mrq), Quick Ratio is recorded 6.21 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 5.30 whereas as Long-Term Debt/Eq ratio is at 5.19.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on June 07, 2024, Downgraded its rating to Neutral and sets its target price to $51 from $48 previously.

On February 29, 2024, TD Cowen started tracking the stock assigning a Outperform rating and target price of $54.

On July 24, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $61.H.C. Wainwright initiated its Buy rating on July 24, 2023, with a $61 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’24 when HELEN TORLEY bought 10,000 shares for $59.09 per share.

HELEN TORLEY bought 10,000 shares of HALO for $590,897 on Sep 10 ’24. On Aug 21 ’24, another insider, LaBarre Michael J., who serves as the SVP, CHIEF TECHNICAL OFFICER of the company, sold 10,000 shares for $61.75 each. As a result, the insider received 617,470 and left with 168,176 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HALO now has a Market Capitalization of 7523406336 and an Enterprise Value of 8527571968. As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.02, and their Forward P/E ratio for the next fiscal year is 12.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.62 while its Price-to-Book (P/B) ratio in mrq is 25.97. Its current Enterprise Value per Revenue stands at 9.765 whereas that against EBITDA is 17.736.

Stock Price History:

Over the past 52 weeks, HALO has reached a high of $65.53, while it has fallen to a 52-week low of $32.83. The 50-Day Moving Average of the stock is 4.59%, while the 200-Day Moving Average is calculated to be 33.39%.

Shares Statistics:

The stock has traded on average 1.31M shares per day over the past 3-months and 1201080 shares per day over the last 10 days, according to various share statistics. A total of 126.77M shares are outstanding, with a floating share count of 125.31M. Insiders hold about 1.08% of the company’s shares, while institutions hold 97.27% stake in the company. Shares short for HALO as of 1723680000 were 9673467 with a Short Ratio of 7.36, compared to 1721001600 on 8708189. Therefore, it implies a Short% of Shares Outstanding of 9673467 and a Short% of Float of 10.35.

Most Popular